IV paricalcitol the clear winner in secondary hyperparathyroidism

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.518, 2006-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IV paricalcitol the clear winner in secondary hyperparathyroidism

By  

Inpharma, Vol. 1, Iss. 1568, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Paricalcitol: A Review of its Use in the Management of Secondary Hyperparathyroidism

By Dean M. Robinson   Lesley J. Scott  

Drugs, Vol. 65, Iss. 4, 2005-01 ,pp. : 559-576

Adis International

Access to resources Recommend Favorite

Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease

By Cheng Steven   Coyne Daniel  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 5, 2006-04 ,pp. : 617-621

Informa Healthcare

Access to resources Recommend Favorite

Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

By Fiedler Roman  

Clinical Drug Investigation, Vol. 27, Iss. 12, 2007-01 ,pp. : 865-866

Adis International

Access to resources Recommend Favorite

Health-Economic Comparison of Paricalcitol, Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism during Haemodialysis

By Rosery Hubertus  

Clinical Drug Investigation, Vol. 26, Iss. 11, 2006-01 ,pp. : 629-638

Adis International

Access to resources Recommend Favorite